← Open Payments lookup

DAVID ROSENSTEIN: Open Payments

NPI 1518001551 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$975 in 49 payments from 16 companies in 2025. Trend: 2023 $1,095 · 2024 $1,165 · 2025 $975

Food & beverage: $975
CompanyPaymentsAmount
GlaxoSmithKline, LLC.9$193
PFIZER INC.9$181
Boehringer Ingelheim Pharmaceuticals, Inc.5$99
ABBVIE INC.4$82
Astellas Pharma US Inc4$81
Novo Nordisk Inc4$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$69
Medtronic, Inc.1$33
Dexcom, Inc.2$28
Otsuka America Pharmaceutical, Inc.1$26

Products named: TRELEGY ELLIPTA, NURTEC ODT, JARDIANCE, UBRELVY, Veozah, CAPLYTA, SHINGRIX, REXULTI.

Industry payments across NV — which companies pay providers there.